- $313.81m
- $3.60bn
- $6.00m
- 18
- 13
- 92
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 348 | 282 | 159 | 150 | 6 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 422 | 632 | 423 | 118 | 279 |
Operating Profit | -74 | -350 | -264 | 32 | -273 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -357 | -578 | -445 | -148 | -484 |
Provision for Income Taxes | |||||
Net Income After Taxes | -359 | -578 | -445 | -149 | -484 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -359 | -578 | -445 | -203 | -491 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -359 | -578 | -445 | -203 | -491 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.89 | -9.78 | -9.6 | -3.04 | -10.1 |
Special Dividends per Share |